Trials / Sponsors / Kaleido Biosciences

Kaleido Biosciences

Industry · 12 registered clinical trials.

Status	Trial	Phase	Started
Completed	An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K0 COVID-19	—	2021-03-25
Completed	A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Struct Mild-to-Moderate COVID-19	N/A	2021-01-12
Completed	A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Str Ulcerative Colitis	N/A	2020-08-12
Completed	A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Ou Mild-to-moderate COVID-19	N/A	2020-08-02
Terminated	UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder Urea Cycle Disorder	Phase 2	2019-09-17
Terminated	VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestina Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects	N/A	2019-06-27
Completed	Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Ci Early Cirrhosis	N/A	2019-02-27
Completed	Clinical Food Study to Evaluate the Effect of KB195 on Gut Nitrogen Metabolism in Patients With Urea Cycle Dis Urea Cycle Disorders	N/A	2019-01-06
Completed	A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects Healthy	N/A	2017-09-18
Completed	A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota Healthy	N/A	2017-09-11
Completed	A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers Healthy	N/A	2015-11-01
Completed	Study to Evaluate the Tolerability of Prebiotics on the Microbiota Healthy	N/A	2015-10-01